ICU MEDICAL INC/DE (ICUI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
52/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseICUI / S&P 13.51% / 15.20% |
LoseICUI / S&P -8.97% / 15.00% |
LoseICUI / S&P -177.78% / 50.40% |
| 2026-Q10/3 |
LoseICUI / S&P -9.48% / -4.33% |
LoseICUI / S&P -10.88% / 11.30% |
LoseICUI / S&P -148.44% / 27.70% |
| 2025-Q41/3 |
WinICUI / S&P 18.93% / 2.65% |
LoseICUI / S&P -6.33% / 9.00% |
LoseICUI / S&P -100.62% / 13.40% |
| 2025-Q30/3 |
LoseICUI / S&P -9.22% / 8.12% |
LoseICUI / S&P -0.84% / 4.61% |
LoseICUI / S&P -93.00% / 13.45% |
| 2025-Q20/3 |
LoseICUI / S&P -4.83% / 10.94% |
LoseICUI / S&P 2.96% / 4.83% |
LoseICUI / S&P -47.60% / 10.63% |
| 2025-Q12/3 |
LoseICUI / S&P -10.51% / -4.27% |
WinICUI / S&P 7.22% / 4.98% |
WinICUI / S&P 56.73% / 10.57% |
| 2024-Q42/3 |
LoseICUI / S&P -14.84% / 2.41% |
WinICUI / S&P 5.44% / 5.25% |
WinICUI / S&P 293.50% / 6.15% |
| 2024-Q32/3 |
WinICUI / S&P 53.45% / 5.89% |
LoseICUI / S&P 4.04% / 5.89% |
WinICUI / S&P 293.97% / 6.11% |
| 2024-Q22/3 |
WinICUI / S&P 10.65% / 4.28% |
LoseICUI / S&P 0.46% / 5.38% |
WinICUI / S&P 45.27% / 5.12% |
| 2024-Q11/3 |
LoseICUI / S&P 7.60% / 10.56% |
LoseICUI / S&P -2.10% / 5.71% |
WinICUI / S&P 28.27% / 5.59% |
| 2023-Q40/3 |
LoseICUI / S&P -16.19% / 11.69% |
LoseICUI / S&P -0.92% / 6.81% |
LoseICUI / S&P -60.45% / 7.78% |
| 2023-Q31/3 |
LoseICUI / S&P -33.21% / -3.27% |
WinICUI / S&P 10.12% / 7.52% |
LoseICUI / S&P -25.64% / -5.03% |
| 2023-Q21/3 |
LoseICUI / S&P 8.02% / 8.74% |
WinICUI / S&P 28.82% / 9.50% |
LoseICUI / S&P -578.57% / -8.57% |
| 2023-Q11/3 |
LoseICUI / S&P 4.75% / 7.50% |
WinICUI / S&P 49.57% / 10.77% |
LoseICUI / S&P -193.63% / -15.69% |
| 2022-Q41/3 |
LoseICUI / S&P 4.57% / 7.56% |
WinICUI / S&P 73.21% / 11.88% |
LoseICUI / S&P -165.61% / -17.99% |
| 2022-Q31/3 |
LoseICUI / S&P -8.39% / -4.88% |
WinICUI / S&P 57.57% / 13.47% |
LoseICUI / S&P -131.01% / -1.41% |
| 2022-Q21/3 |
LoseICUI / S&P -26.16% / -16.10% |
WinICUI / S&P 39.26% / 13.71% |
LoseICUI / S&P -91.18% / 11.04% |
| 2022-Q11/3 |
LoseICUI / S&P -6.19% / -4.60% |
WinICUI / S&P 22.29% / 15.97% |
LoseICUI / S&P -52.89% / 42.23% |
| 2021-Q40/3 |
LoseICUI / S&P 1.70% / 11.03% |
LoseICUI / S&P 3.56% / 15.00% |
LoseICUI / S&P 17.91% / 96.40% |
| 2021-Q31/3 |
WinICUI / S&P 13.40% / 0.58% |
LoseICUI / S&P 2.38% / 10.77% |
LoseICUI / S&P 33.07% / 69.42% |
| 2021-Q20/3 |
LoseICUI / S&P 0.18% / 8.55% |
LoseICUI / S&P 1.89% / 6.58% |
LoseICUI / S&P 23.32% / 51.81% |
| 2021-Q11/3 |
LoseICUI / S&P -4.22% / 6.17% |
WinICUI / S&P -0.27% / -1.06% |
LoseICUI / S&P 7.18% / 7.39% |
| 2020-Q43/3 |
WinICUI / S&P 17.36% / 12.15% |
WinICUI / S&P 0.38% / -3.72% |
WinICUI / S&P -14.47% / -33.42% |
| 2020-Q32/3 |
LoseICUI / S&P -0.84% / 8.93% |
WinICUI / S&P -1.94% / -2.04% |
WinICUI / S&P 11.18% / -27.10% |
| 2020-Q21/3 |
LoseICUI / S&P -8.65% / 20.54% |
LoseICUI / S&P -4.26% / -0.46% |
WinICUI / S&P 77.88% / -27.11% |
| 2020-Q12/3 |
WinICUI / S&P 7.83% / -19.60% |
LoseICUI / S&P -6.99% / 3.47% |
WinICUI / S&P 58.43% / -14.75% |
| 2019-Q42/3 |
WinICUI / S&P 17.24% / 9.07% |
LoseICUI / S&P -9.56% / 5.36% |
WinICUI / S&P 250.75% / 2.99% |
| 2019-Q30/3 |
LoseICUI / S&P -36.64% / 1.70% |
LoseICUI / S&P -9.70% / 5.02% |
LoseICUI / S&P -16.05% / 0.21% |
| 2019-Q21/3 |
WinICUI / S&P 5.26% / 4.30% |
LoseICUI / S&P -9.34% / 6.64% |
LoseICUI / S&P -46.42% / 8.65% |
| 2019-Q11/3 |
LoseICUI / S&P 4.22% / 13.65% |
LoseICUI / S&P -4.09% / 8.12% |
WinICUI / S&P 244.59% / 14.29% |
| 2018-Q40/3 |
LoseICUI / S&P -18.79% / -13.52% |
LoseICUI / S&P 8.31% / 9.05% |
LoseICUI / S&P -60.24% / 18.23% |
| 2018-Q32/3 |
LoseICUI / S&P -3.71% / 7.71% |
WinICUI / S&P 40.43% / 10.21% |
WinICUI / S&P 164.71% / 19.06% |
| 2018-Q23/3 |
WinICUI / S&P 16.34% / 3.43% |
WinICUI / S&P 87.27% / 9.03% |
WinICUI / S&P 55.17% / 14.46% |
| 2018-Q12/3 |
WinICUI / S&P 16.85% / -0.76% |
WinICUI / S&P 163.73% / 7.68% |
LoseICUI / S&P -86.45% / 12.46% |
| 2017-Q42/3 |
WinICUI / S&P 16.22% / 6.64% |
WinICUI / S&P 240.72% / 7.03% |
LoseICUI / S&P -8.42% / 13.82% |
| 2017-Q32/3 |
WinICUI / S&P 7.74% / 4.48% |
WinICUI / S&P 172.19% / 5.68% |
LoseICUI / S&P -55.91% / 17.57% |
| 2017-Q22/3 |
WinICUI / S&P 12.97% / 3.09% |
WinICUI / S&P 112.70% / 4.83% |
LoseICUI / S&P -22.32% / 17.74% |
| 2017-Q12/3 |
LoseICUI / S&P 3.63% / 6.07% |
WinICUI / S&P 53.48% / 3.67% |
WinICUI / S&P 70.09% / 13.32% |
| 2016-Q43/3 |
WinICUI / S&P 16.59% / 3.82% |
WinICUI / S&P 11.04% / 2.09% |
WinICUI / S&P 34.80% / 7.05% |
| 2016-Q33/3 |
WinICUI / S&P 12.09% / 3.85% |
WinICUI / S&P 12.95% / 0.20% |
WinICUI / S&P 20.91% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ICUI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 37.16% | 20.78% |
| Annualized return | 37.16% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ICUI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -12.62% | 83.14% |
| Annualized return | -2.66% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ICUI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 39.85% | 319.30% |
| Annualized return | 3.41% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |